Systemic Solutions in Retinopathy of Prematurity.

PURPOSE: To describe a framework for screening and treatment of retinopathy of prematurity (ROP) using telemedicine screening with laser and/or vascular endothelial growth factor inhibitor treatment strategies.

DESIGN

Literature review and perspective.

METHODS

Review of the literature and the author's experience.

RESULTS

Undetermined.

CONCLUSIONS

Telemedicine can be deployed on a national basis to provide quaternary-level screening for ROP. At-risk patients for treatment could then be directed to receive either laser photocoagulation or vascular endothelial growth factor inhibitor intravitreal injections followed at a later time by examination under anesthesia, fluorescein angiography, and diode laser photocoagulation as indicated.